Janus Henderson Group PLC boosted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 31.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,005 shares of the company's stock after purchasing an additional 17,641 shares during the period. Janus Henderson Group PLC owned approximately 0.40% of Addus HomeCare worth $9,150,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the stock. Barclays PLC raised its stake in shares of Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company's stock valued at $5,783,000 after purchasing an additional 29,207 shares during the period. Ellsworth Advisors LLC increased its stake in Addus HomeCare by 6.5% during the 4th quarter. Ellsworth Advisors LLC now owns 5,692 shares of the company's stock worth $713,000 after buying an additional 348 shares during the period. Sheets Smith Wealth Management lifted its holdings in Addus HomeCare by 3.2% in the 4th quarter. Sheets Smith Wealth Management now owns 7,005 shares of the company's stock worth $878,000 after buying an additional 218 shares in the last quarter. Dakota Wealth Management boosted its position in Addus HomeCare by 24.2% in the 4th quarter. Dakota Wealth Management now owns 2,024 shares of the company's stock valued at $254,000 after buying an additional 394 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in Addus HomeCare by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after buying an additional 91 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
ADUS has been the topic of a number of analyst reports. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Wall Street Zen downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Macquarie upped their target price on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Stephens restated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $142.57.
Read Our Latest Report on Addus HomeCare
Addus HomeCare Trading Up 0.6%
NASDAQ ADUS traded up $0.63 on Friday, hitting $112.16. 181,565 shares of the stock traded hands, compared to its average volume of 167,317. The stock has a 50-day moving average of $102.28 and a 200 day moving average of $113.32. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a market capitalization of $2.06 billion, a P/E ratio of 25.67, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same period in the previous year, the business earned $1.21 EPS. The business's quarterly revenue was up 20.3% on a year-over-year basis. As a group, equities research analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.